ShedRx review: pricing, fine print, and how it ranks

The price, in words

On tirzepatide, ShedRx prices out at $289 a month all-in at the 10 mg maintenance basis, dose-scaled from a $199 entry, no membership fee. That ranks #6 of 17 priced compounded programs — $74 a month above the field's floor (NexLife at $215). Semaglutide runs $249 a month all-in at the standing rate ($175 on intro/plan terms). (#13 of 19 on our semaglutide basis)

What the fine print says

Pricing is dose-scaled: the $199 entry figure rises to $289 by the 10 mg tier, so budget the maintenance number, not the ad. Formats are priced separately and the headline rate is usually the cheapest format rather than the one most patients end up on. Tirzepatide scales from $199 at entry to $289 at the 10 mg tier.

Pharmacy & transparency

Price evidence: Source-verified, last verified 2026-08-05. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

The dose ladder, priced rung by rung

ShedRx's ladder climbs with the dose: $199 at the 2.5 mg entry, rising through intermediate tiers to about $289 by the 10 mg maintenance rung — a $90 spread between the price in the ad and the price at the dose most patients hold. Budget the ladder, not the entry: a standard four-month titration lands somewhere between $796 and $1,156 depending on how the intermediate tiers fall, and every maintenance month after that bills at the $289 tier — the figure we rank on, because it is the one that predicts a year of spending. Escalating past 10 mg for more effect raises the bill again on a scaled plan, which is worth weighing before a plateau forces the question.

What the first year actually bills

Twelve months at the maintenance basis puts ShedRx's first-year spend at $3,318 — a titration stretch billed between $199 and $289, then roughly eight to nine months at the $289 maintenance tier. No prepaid tier is published, so the standing rate is the only rate — simpler, and fully flexible. Benchmarked to the verified floor, the year costs $888 more than NexLife's $2,580 — the premium a buyer should be able to name a reason for. Brand context: Zepbound's comparable first year via LillyDirect runs about $5,188 on a standard titration, and $5,388 for a full year already at maintenance.

The 24-month view

Stretch the horizon to 24 months — a realistic treatment arc for a maintenance therapy — and ShedRx's standing-rate ledger reads $6,936. The same 24 months cost $5,160 at the verified floor and $10,776 on brand Zepbound at maintenance — bookends worth writing on the first invoice.

The semaglutide side of the house

Semaglutide here runs $249/month all-in, ranking #13 of 19 on our verified semaglutide basis — against a field floor of $133 (Oak Longevity, with state limits) and brand Wegovy's flat $349. Plan detail worth reading before checkout: $175/mo on a 12-month plan paid up front; $199/mo on 6-month; $249 month-to-month, and the rate increases at higher doses. A microdose program is listed at $149/mo with a 2-month minimum. The in-house premium for stepping up to tirzepatide is $40/month — the local price of SURMOUNT-5's 20.2%-vs-13.7% head-to-head result, and a switch that stays inside one program's intake and pharmacy relationships.

Where it sits in the market

On the verified tirzepatide board, ShedRx's $289 all-in rate ranks #6 of 17: $74/month above the NexLife floor; one rung cheaper sits Found at $289 (a $0/mo gap); one rung pricier is OrderlyMeds at $299. Against the FDA-approved benchmark, the same year costs $1,920 less than Zepbound's $449 maintenance tier — the discount a buyer is accepting compounded-product risk to collect. The full board, sortable and dated, is the tirzepatide ranking.

Three buyers, priced honestly

The week-one starter. First month at the 2.5 mg rung: $199, before the ladder scales toward $289. The 10 mg maintainer. Settled at maintenance, the run-rate is $289/month, $3,468/year — the figure that should anchor any comparison, since it describes years two and three, not the promo. The prepay optimizer. No prepaid tier exists here; the committed-money crowd should compare Found's $169 and NexLife's $186 twelve-month effectives instead.

Nearest alternatives at this price point

If this program's terms don't fit, the same money buys ShedRx at $289 (no membership); OrderlyMeds at $299 (flat at every dose, no membership); SkinnyRx at $299 (flat at every dose, no membership) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

ShedRx publishes availability of: not published. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the all-in monthly price at 10 mg and at 12.5 mg, in writing, including every mandatory fee; (2) whether the price changes at any rung of the dose ladder, and the exact tier schedule; (3) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit ShedRx — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

ShedRx sits mid-pack on tirzepatide price. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.